Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone acetate
Drug ID BADD_D01434
Description Methylprednisolone is a [prednisolone] derivative glucocorticoid with higher potency than [prednisone].[A188811] It was first described in the literature in the late 1950s.[A188811,A188814] Methylprednisolone was granted FDA approval on 24 October 1957.[L10785] In the outbreak of COVID-19, low dose methylprednisolone-based therapy was successful in treating COVID-19-associated pneumonia in one patient with long-term immunosuppression.[A192813] The efficacy of methylprednisolone in novel coronavirus pneumonia is being investigated further in clinical trials.[L12666]
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB00959
KEGG ID D00979
MeSH ID D000077555
PubChem ID 5877
TTD Drug ID Not Available
NDC Product Code 50090-0436; 0009-0306; 0009-3475; 38779-0144; 50090-4802; 70518-2894; 50090-0312; 46439-8767; 0009-0274; 60219-1573; 25021-821; 0009-0280; 0009-3073; 50090-0556; 70518-2914; 63187-474; 50090-5894; 16714-089; 0703-0045; 25021-820; 0703-0043; 76420-081; 0703-0063; 70518-2965; 51927-0000; 16714-472; 51552-0958; 70518-2459; 70518-3071; 70121-1552; 50090-1823; 16714-473; 49452-4688; 0703-0051; 70121-1573; 51662-1429; 0009-0026; 76420-260; 0703-0031; 10695-041; 76420-262; 16714-090; 22552-0023; 63275-9942; 68788-8082; 60219-1574; 70121-1574; 70518-2915; 50090-2098; 65089-0016; 16714-088; 82298-117; 52128-148
Synonyms Methylprednisolone Acetate | Methylprednisolone-21-acetate | Methylprednisolone 21 acetate | Acetyl-Methylprednisolone | Acetyl Methylprednisolone | Depo-Medrone | Depo Medrone | Depo-Medrol | Depo Medrol | Methylprednisolone Acetate, (11beta,16beta)-isomer | Methylprednisolone Acetate, (11beta,16alpha)-isomer
Chemical Information
Molecular Formula C24H32O6
CAS Registry Number 53-36-1
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Abscess sterile08.01.05.008--Not Available
Acne23.02.01.001--Not Available
Affective disorder19.04.04.001--Not Available
Alanine aminotransferase increased13.03.01.003--
Alkalosis hypokalaemic14.01.02.002--Not Available
Alopecia23.02.02.001--
Amenorrhoea21.01.02.001; 05.05.01.002--
Amnesia19.20.01.001; 17.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Anxiety19.06.02.002--
Arachnoiditis12.02.04.002; 17.06.01.001--
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.001--
Arthropathy15.01.01.003--Not Available
Aspartate aminotransferase increased13.03.01.006--
Asthenia08.01.01.001--Not Available
Atrophy08.03.04.001--Not Available
Benign intracranial hypertension17.07.02.001--Not Available
Blindness17.17.01.003; 06.02.02.001--Not Available
Blood calcium increased13.11.01.003--Not Available
Blood potassium decreased13.11.01.010--Not Available
Blood urea increased13.13.01.006--Not Available
Bradycardia02.03.02.002--Not Available
Calcinosis08.03.04.002--Not Available
Carbohydrate tolerance decreased13.02.02.003--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 8 Pages